SOLVENTUM CORPORATION Effective Tax Rate
SOLVENTUM CORPORATION (SOLV) reported Effective Tax Rate of 14.40% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-05
- SOLVENTUM CORPORATION effective income tax rate reconciliation, percent for the quarter ending 2026-06-30 was 14.40%, a 15.20% increase year-over-year.
- SOLVENTUM CORPORATION effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was 19.30%.
- SOLVENTUM CORPORATION effective income tax rate reconciliation, percent for the quarter ending 2025-09-30 was 16.40%, a 39.03% decline year-over-year.
- SOLVENTUM CORPORATION effective income tax rate reconciliation, percent for the quarter ending 2025-06-30 was 12.50%, a 71.23% increase year-over-year.
- SOLVENTUM CORPORATION effective income tax rate reconciliation, percent for fiscal 2025 was 9.20%, a 55.98% decline from fiscal 2024.
- SOLVENTUM CORPORATION effective income tax rate reconciliation, percent for fiscal 2024 was 20.90%, a 8.29% increase from fiscal 2023.
- SOLVENTUM CORPORATION effective income tax rate reconciliation, percent for fiscal 2023 was 19.30%, a 6.31% decline from fiscal 2022.
- SOLVENTUM CORPORATION effective income tax rate reconciliation, percent for fiscal 2022 was 20.60%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|
| 2026-06-30 | 14.40% 10-Q · filed 2026-08-05 | 15.00% 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | 19.30% 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | 9.20% 10-K · filed 2026-02-27 | |||
| 2025-09-30 | 16.40% 10-Q · filed 2025-11-06 | 9.80% 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 12.50% 10-Q · filed 2026-08-05 | -61.00% 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | -262.10% 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | 20.90% 10-K · filed 2026-02-27 | |||
| 2024-09-30 | 26.90% 10-Q · filed 2025-11-06 | 24.30% 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | 7.30% 10-Q · filed 2025-08-08 | 23.30% 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | 28.00% 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | 19.30% 10-K · filed 2026-02-27 | |||
| 2023-09-30 | 8.00% 10-Q · filed 2024-11-08 | 15.80% 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | 22.30% 10-Q · filed 2024-08-09 | 20.90% 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | 19.30% 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | 20.60% 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |